232 related articles for article (PubMed ID: 31810462)
1. Influence of combined functional resistance and endurance exercise over 12 weeks on matrix metalloproteinase-2 serum concentration in persons with relapsing-remitting multiple sclerosis - a community-based randomized controlled trial.
Proschinger S; Joisten N; Rademacher A; Schlagheck ML; Walzik D; Metcalfe AJ; Oberste M; Warnke C; Bloch W; Schenk A; Bansi J; Zimmer P
BMC Neurol; 2019 Dec; 19(1):314. PubMed ID: 31810462
[TBL] [Abstract][Full Text] [Related]
2. Influence of different rehabilitative aerobic exercise programs on (anti-) inflammatory immune signalling, cognitive and functional capacity in persons with MS - study protocol of a randomized controlled trial.
Joisten N; Rademacher A; Bloch W; Schenk A; Oberste M; Dalgas U; Langdon D; Caminada D; Purde MT; Gonzenbach R; Kool J; Zimmer P; Bansi J
BMC Neurol; 2019 Mar; 19(1):37. PubMed ID: 30849952
[TBL] [Abstract][Full Text] [Related]
3. Erratum.
Mult Scler; 2016 Oct; 22(12):NP9-NP11. PubMed ID: 26041800
[TBL] [Abstract][Full Text] [Related]
4. High-intensity interval training and energy management education, compared with moderate continuous training and progressive muscle relaxation, for improving health-related quality of life in persons with multiple sclerosis: study protocol of a randomized controlled superiority trial with six months' follow-up.
Patt N; Kool J; Hersche R; Oberste M; Walzik D; Joisten N; Caminada D; Ferrara F; Gonzenbach R; Nigg CR; Kamm CP; Zimmer P; Bansi J
BMC Neurol; 2021 Feb; 21(1):65. PubMed ID: 33573608
[TBL] [Abstract][Full Text] [Related]
5. Cycling in primary progressive multiple sclerosis (CYPRO): study protocol for a randomized controlled superiority trial evaluating the effects of high-intensity interval training in persons with primary progressive multiple sclerosis.
Kupjetz M; Joisten N; Rademacher A; Gonzenbach R; Bansi J; Zimmer P
BMC Neurol; 2023 Apr; 23(1):162. PubMed ID: 37087424
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Dietary approaches to treat MS-related fatigue: comparing the modified Paleolithic (Wahls Elimination) and low saturated fat (Swank) diets on perceived fatigue in persons with relapsing-remitting multiple sclerosis: study protocol for a randomized controlled trial.
Wahls T; Scott MO; Alshare Z; Rubenstein L; Darling W; Carr L; Smith K; Chenard CA; LaRocca N; Snetselaar L
Trials; 2018 Jun; 19(1):309. PubMed ID: 29866196
[TBL] [Abstract][Full Text] [Related]
8. Rituximab for relapsing-remitting multiple sclerosis.
He D; Guo R; Zhang F; Zhang C; Dong S; Zhou H
Cochrane Database Syst Rev; 2013 Dec; (12):CD009130. PubMed ID: 24310855
[TBL] [Abstract][Full Text] [Related]
9. The TOTEM RRMS (Testosterone Treatment on neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis) trial: study protocol for a randomized, double-blind, placebo-controlled trial.
Metzger-Peter K; Kremer LD; Edan G; Loureiro De Sousa P; Lamy J; Bagnard D; Mensah-Nyagan AG; Tricard T; Mathey G; Debouverie M; Berger E; Kerbrat A; Meyer N; De Seze J; Collongues N
Trials; 2020 Jun; 21(1):591. PubMed ID: 32600454
[TBL] [Abstract][Full Text] [Related]
10. High-intensity interval exercise improves cognitive performance and reduces matrix metalloproteinases-2 serum levels in persons with multiple sclerosis: A randomized controlled trial.
Zimmer P; Bloch W; Schenk A; Oberste M; Riedel S; Kool J; Langdon D; Dalgas U; Kesselring J; Bansi J
Mult Scler; 2018 Oct; 24(12):1635-1644. PubMed ID: 28825348
[TBL] [Abstract][Full Text] [Related]
11. Aerobic exercise increases irisin serum levels and improves depression and fatigue in patients with relapsing remitting multiple sclerosis: A randomized controlled trial.
Bilek F; Cetisli-Korkmaz N; Ercan Z; Deniz G; Demir CF
Mult Scler Relat Disord; 2022 May; 61():103742. PubMed ID: 35349884
[TBL] [Abstract][Full Text] [Related]
12. Persons with secondary progressive and relapsing remitting multiple sclerosis reveal different responses of tryptophan metabolism to acute endurance exercise and training.
Bansi J; Koliamitra C; Bloch W; Joisten N; Schenk A; Watson M; Kool J; Langdon D; Dalgas U; Kesselring J; Zimmer P
J Neuroimmunol; 2018 Jan; 314():101-105. PubMed ID: 29224960
[TBL] [Abstract][Full Text] [Related]
13. Investigation of in-phase bilateral exercise effects on corticospinal plasticity in relapsing remitting multiple sclerosis: A registered report single-case concurrent multiple baseline design across five subjects.
Sokratous D; Charalambous CC; Papanicolaou EZ; Michailidou K; Konstantinou N
PLoS One; 2023; 18(3):e0272114. PubMed ID: 36862693
[TBL] [Abstract][Full Text] [Related]
14. Brain derived neurotrophic factor in multiple sclerosis: effect of 24 weeks endurance and resistance training.
Wens I; Keytsman C; Deckx N; Cools N; Dalgas U; Eijnde BO
Eur J Neurol; 2016 Jun; 23(6):1028-35. PubMed ID: 26992038
[TBL] [Abstract][Full Text] [Related]
15. Multimodal agility-based exercise training (MAT) versus strength and endurance training (SET) to improve multiple sclerosis-related fatigue and fatigability during inpatient rehabilitation: a randomized controlled pilot and feasibility study [ReFEx].
Wolf F; Nielsen J; Saliger J; Hennecken E; Kröber P; Eschweiler M; Folkerts AK; Karbe H; Zimmer P
BMC Neurol; 2023 Oct; 23(1):388. PubMed ID: 37898772
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-9 and matrix metalloproteinase-2 as biomarkers of various courses in multiple sclerosis.
Benesová Y; Vasku A; Novotná H; Litzman J; Stourac P; Beránek M; Kadanka Z; Bednarík J
Mult Scler; 2009 Mar; 15(3):316-22. PubMed ID: 19153173
[TBL] [Abstract][Full Text] [Related]
17. Effect of combined exercise training on pentraxins and pro- inflammatory cytokines in people with multiple sclerosis as a function of disability status.
Faramarzi M; Banitalebi E; Raisi Z; Samieyan M; Saberi Z; Mardaniyan Ghahfarrokhi M; Negaresh R; Motl RW
Cytokine; 2020 Oct; 134():155196. PubMed ID: 32683106
[TBL] [Abstract][Full Text] [Related]
18. Serum matrix metalloproteinase-3 levels correlate with disease activity in relapsing-remitting multiple sclerosis.
Kanesaka T; Mori M; Hattori T; Oki T; Kuwabara S
J Neurol Neurosurg Psychiatry; 2006 Feb; 77(2):185-8. PubMed ID: 16421119
[TBL] [Abstract][Full Text] [Related]
19. Progressive resistance training did not improve walking but can improve muscle performance, quality of life and fatigue in adults with multiple sclerosis: a randomized controlled trial.
Dodd KJ; Taylor NF; Shields N; Prasad D; McDonald E; Gillon A
Mult Scler; 2011 Nov; 17(11):1362-74. PubMed ID: 21677021
[TBL] [Abstract][Full Text] [Related]
20. Exercise therapy for fatigue in multiple sclerosis.
Heine M; van de Port I; Rietberg MB; van Wegen EE; Kwakkel G
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009956. PubMed ID: 26358158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
